Amatem contains Artemether 80 mg, Lumefantrine 480 mg. Do not use during breastfeeding and pregnancy unless it is specifically recommended by a medical doctor. Breastfeeding women should not use Artemether and Lumefantrine tablets due to the long elimination half-life of Lumefantrine (4 to 6 days).
It is recommended that breastfeeding should not resume before day 28 after discontinuation of Artemether and Lumefantrine combination unless potential benefits to mother and child outweigh the risk of the combination treatment.
Expecting? Start Tracking your baby's development week by week below
It is recommended that breastfeeding should not resume before day 28 after discontinuation of Artemether and Lumefantrine combination unless potential benefits to mother and child outweigh the risk of the combination treatment.